Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cells with high metabolic activity exhibit altered energy production and biosynthetic pathways, including increased glucose uptake and aerobic glycolysis (Warburg effect), altered mitochondrial function, and increased glutamine metabolism. These changes support rapid proliferation, survival in nutrient-poor environments, and adaptation to stress. Targeting these metabolic alterations is an emerging therapeutic strategy.
Inhibition of key metabolic enzymes or pathways to disrupt cancer cell energy production and biosynthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell with High Metabolic Activity (N/A).